Developer docs
API playgroundTry for free, no card

Search company profiles

Laysan Bio

Full company profile

uuid000c356

Namestring
Laysan Bio
Legal namestring
Laysan Bio, Inc.
Websiteurl
laysanbio.com
Company typeenum
Private
Founded yearint
2006
Descriptiontext

Laysan Bio, Inc. is a privately-held life sciences company founded in 2006 and headquartered in Arab, Alabama, that manufactures and supplies activated polyethylene glycol (PEG) reagents and related bioconjugation chemistries used in pharmaceutical, drug delivery, and medical device applications. Its product portfolio spans monofunctional, bifunctional, heterobifunctional, and multi-arm PEG reagents organized across more than 20 functional-group categories — including esters (NHS, SAS, SC, SG, SS, SVA), maleimides, amines, aldehydes, biotins, carboxylic acids, epoxides, hydrazides, hydroxyls, phospholipids, thiols, silanes, and valeric acids — together with cGMP-manufactured product lines and pre-packaged conjugation kits. The company states its reagents have been qualified into multiple FDA and EU-approved drug and device products, evidencing quality system maturity relevant to regulated therapeutic and medical device supply chains.

The business operates as a specialty chemicals supplier serving pharmaceutical companies (primary segment), medical device manufacturers, and drug delivery developers. Revenue is generated through unit-priced catalog sales via a direct e-commerce storefront, with per-SKU pricing ranging from approximately $24 to $1,200 and quantity-based tier discounts. Technical documentation (MSDS, SDS, product information sheets, hydrolysis half-life data) and direct customer support (sales@laysanbio.com, phone) supplement the catalog motion, with custom reagent inquiries handled directly. On January 22, 2026, Laysan Bio was acquired by Gannet BioChem, a specialty CDMO backed by Ampersand Capital Partners, and the commercial offering is now delivered under the unified "Gannet BioChem & Laysan Bio" brand through the consolidated catalog.gannetbiochem.com storefront, extending the company's reach from reagent supply into an end-to-end CDMO platform serving advanced therapeutic, drug delivery, and medical device programs from early development through GMP manufacturing.

Short descriptiontext

Laysan Bio is a privately-held life sciences company that manufactures activated polyethylene glycol (PEG) reagents and bioconjugation chemistries used by pharmaceutical, drug delivery, and medical device developers, now operating as a subsidiary of CDMO Gannet BioChem.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersArab, United States
HQ citystring
Arab
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
PEG reagents, bioconjugation services, activated polymers, pharmaceutical manufacturing, drug delivery chemicals
Industry2 codes
PRIMARYHLAGAHAI
Solid-State Chemistry & Preformulation (Polymorph/Crystallization)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYIMANABAK
Medical & Food-Contact Specialty Compounds
NAICS code1 code
  • Pharmaceutical and Medicine Manufacturing32541
SIC code1 code
  • Plastic Materials, Synth Resins & Nonvulcan Elastomers2821
Product category
PEG Reagents
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1PEG Reagent Product Sales
TypeOne Time License
Description

Sale of activated polyethylene glycol reagents and related chemical products to pharmaceutical, biotechnology, and medical device companies. Products sold include cGMP-manufactured and catalog products across multiple functional categories (Esters, Maleimides, Amines, etc.). Pricing ranges from $24 to $1,200 depending on product type and quantity.

catalog.gannetbiochem.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Pricing details1 tier
1Individual PEG reagent products with quantity-based pricing
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Product pricing varies by reagent type and quantity. Example prices: MAL-PEG-SVA ranges from $195 to $1,200; mPEG2-NHS ranges from $275 to $825; mPEG2-MAL ranges from $270 to $810; NH2-PEG-NH2 ranges from $24 to $270; SAS-PEG-SAS ranges from $65 to $345. Volume discounts available through quantity-based tier pricing.

catalog.gannetbiochem.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Laysan Bio manufactures and supplies activated polyethylene glycol (PEG) reagents for pharmaceutical, biotechnology, and medical device applications. The product portfolio spans cGMP-manufactured PEGs and catalog-grade reagents across monofunctional, bifunctional, heterobifunctional, and multi-arm configurations, with over 20 functional group categories including esters, maleimides, amines, thiols, aldehydes, biotins, carboxylic acids, epoxides, and phospholipids. The company also offers bioconjugation expertise to support drug formulation, protein modification, drug delivery systems, and medical device functionalization.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Laysan Bio is a life sciences company that supplies activated polyethylene glycol (PEG) reagents for use in therapeutics, devices, and diagnostics. Founded in 1992, the company has supplied PEG reagents for multiple FDA and EU-approved drug and device products. The product portfolio is organized into several categories: cGMP Products for commercial manufacturing; Monofunctional, Bifunctional, Heterobifunctional, and Multi-Arm PEG reagents; and Kits for specific conjugation applications. Products are further categorized by functional group including Esters (NHS, SAS, SC, SG, SS, SVA), Maleimides (MAL), Amines (NH2), Thiols (SH), Aldehydes, Acrylates, Epoxides, Hydrazides, Hydroxyls, Nitrophenyl Carbonates, Orthopyridyl Disulfides, Phospholipids, Protected Amines, Silanes, Biotins, Carboxylic Acids, and Valeric Acids. Featured products include MAL-PEG-SVA (heterobifunctional), mPEG2-NHS (monofunctional), mPEG-SH-4MW KIT (thiol kit), and mPEG2-MAL (monofunctional). The company operates a robust quality system supporting cGMP-manufactured products. In January 2026, Laysan Bio was acquired by Gannet BioChem, a specialty Contract Development and Manufacturing Organization backed by Ampersand Capital Partners.

Product and service13 records
1cGMP PEG Products
CategorycGMP Manufacturing
2Monofunctional PEG Reagents
CategoryPEG Reagents
3Bifunctional PEG Reagents
CategoryPEG Reagents
4Heterobifunctional PEG Reagents
CategoryPEG Reagents
5Multi-Arm (4 Arm) PEG Reagents
CategoryPEG Reagents
6PEG Reagent Kits
CategoryPEG Reagents
7MAL-PEG-SVA
CategoryPEG Reagents
Description

Heterobifunctional PEG reagent with maleimide (MAL) and succinimidyl valerate (SVA) functional groups for site-specific protein and peptide conjugation. Price range: $195.00 to $1,200.00.

8mPEG2-NHS
CategoryPEG Reagents
Description

Monofunctional PEG reagent with N-hydroxysuccinimide (NHS) ester for amine-reactive bioconjugation to proteins and peptides. Price range: $275.00 to $825.00.

9mPEG-SH-4MW KIT
CategoryPEG Reagents
Description

mPEG-thiol kit with 4 molecular weight options for thiol-reactive conjugation and crosslinking applications. Price: $120.00.

10mPEG2-MAL
CategoryPEG Reagents
Description

Monofunctional PEG reagent with maleimide functional group for selective thiol-reactive bioconjugation. Price range: $270.00 to $810.00.

11NH2-PEG-NH2
CategoryPEG Reagents
Description

Bifunctional amine PEG reagent for crosslinking applications with primary amine reactivity. Price range: $24.00 to $270.00.

12ACRL-PEG-ACRL
CategoryPEG Reagents
Description

Bifunctional acrylate PEG reagent for polymerizable conjugation and surface modification applications. Price range: $50.00 to $300.00.

13SAS-PEG-SAS
CategoryPEG Reagents
Description

Bifunctional PEG reagent with succinimidyl succinate (SAS) ester groups for amine-reactive applications. Price range: $65.00 to $345.00.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierFlagshipTypeOthersAnnounced on2026-01-22
Description

Gannet BioChem, a specialty Contract Development and Manufacturing Organization (CDMO), acquired Laysan Bio to expand its activated polymer and bioconjugation capabilities. The acquisition combines Laysan Bio's technical expertise, quality systems, and customer relationships with Gannet BioChem's CDMO platform serving advanced therapeutic, drug delivery, and medical device programs. Post-acquisition, Laysan Bio operates as part of Gannet BioChem's integrated platform.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1NOF Corporation
TypeDirect peer
Description

NOF Corporation is a leading manufacturer of specialty chemicals with an established PEG reagent and bioconjugation business (including SUNBRIGHT® activated PEGs) serving pharmaceutical and medical device customers globally — directly overlapping with Laysan Bio's core activated PEG reagent offering.

TypeBroad incumbent
Description

TCI America supplies specialty chemicals, including PEG derivatives and activated reagents, to pharma, biotech, and academic customers — competing in adjacent SKUs with Laysan Bio's PEG reagent catalog across broader specialty chemistry.

TypeDirect peer
Description

Polysciences manufactures specialty polymers, monomers, and PEG derivatives for life sciences and biomedical applications, with directly overlapping specialty polymer chemistry capabilities and shared pharmaceutical/biotech customers.

TypeDirect peer
Description

Creative PEGWorks specializes in activated PEG derivatives and PEGylation reagents for drug delivery and bioconjugation, with a catalog and customer base that directly overlap with Laysan Bio's PEG reagent product line.

TypeOthers
Description

Gannet BioChem is now Laysan Bio's parent company and a specialty CDMO supporting advanced therapeutics and drug delivery programs. As the acquirer/platform, it is operationally integrated with Laysan Bio and offers the broader CDMO context in which Laysan Bio's PEG reagents are commercialized.

TypeDirect peer
Description

BroadPharm is a manufacturer of activated PEG reagents and PEG derivatives serving pharma, biotech, and academic customers with a catalog comparable in scope to Laysan Bio's, including bioconjugation and drug delivery applications.

TypeBroad incumbent
Description

Thermo Fisher Scientific supplies PEG reagents, bioconjugation products, and specialty chemicals within a much broader life sciences tools and reagents portfolio, providing commercial-stage alternatives for many of Laysan Bio's pharmaceutical and biotech customers.

8Quanta BioDesign
TypeDirect peer
Description

Quanta BioDesign develops and supplies PEG derivatives and dPEG®-based linkers for bioconjugation and drug delivery research and manufacturing, directly comparable to Laysan Bio's specialty PEG reagent and bioconjugation offerings.

9MilliporeSigma (Sigma-Aldrich)
TypeBroad incumbent
Description

MilliporeSigma, the life science business of Merck KGaA, is a broad incumbent supplying catalog PEG reagents, specialty chemicals, and bioconjugation consumables alongside a much larger life sciences portfolio — competing with Laysan Bio across many of the same functional PEG reagent SKUs.

10Jenkem Technology USA
TypeDirect peer
Description

Jenkem Technology manufactures and globally distributes activated PEG reagents with broad functional-group coverage, directly competing with Laysan Bio in monofunctional, bifunctional, heterobifunctional, and multi-arm PEG reagents for bioconjugation applications.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Laysan Bio

PEG Reagentslaysanbio.com

Laysan Bio is a privately-held life sciences company that manufactures activated polyethylene glycol (PEG) reagents and bioconjugation chemistries used by pharmaceutical, drug delivery, and medical device developers, now operating as a subsidiary of CDMO Gannet BioChem.

What Laysan Bio does

Laysan Bio, Inc. is a privately-held life sciences company founded in 2006 and headquartered in Arab, Alabama, that manufactures and supplies activated polyethylene glycol (PEG) reagents and related bioconjugation chemistries used in pharmaceutical, drug delivery, and medical device applications. Its product portfolio spans monofunctional, bifunctional, heterobifunctional, and multi-arm PEG reagents organized across more than 20 functional-group categories — including esters (NHS, SAS, SC, SG, SS, SVA), maleimides, amines, aldehydes, biotins, carboxylic acids, epoxides, hydrazides, hydroxyls, phospholipids, thiols, silanes, and valeric acids — together with cGMP-manufactured product lines and pre-packaged conjugation kits. The company states its reagents have been qualified into multiple FDA and EU-approved drug and device products, evidencing quality system maturity relevant to regulated therapeutic and medical device supply chains.

The business operates as a specialty chemicals supplier serving pharmaceutical companies (primary segment), medical device manufacturers, and drug delivery developers. Revenue is generated through unit-priced catalog sales via a direct e-commerce storefront, with per-SKU pricing ranging from approximately $24 to $1,200 and quantity-based tier discounts. Technical documentation (MSDS, SDS, product information sheets, hydrolysis half-life data) and direct customer support (sales@laysanbio.com, phone) supplement the catalog motion, with custom reagent inquiries handled directly. On January 22, 2026, Laysan Bio was acquired by Gannet BioChem, a specialty CDMO backed by Ampersand Capital Partners, and the commercial offering is now delivered under the unified "Gannet BioChem & Laysan Bio" brand through the consolidated catalog.gannetbiochem.com storefront, extending the company's reach from reagent supply into an end-to-end CDMO platform serving advanced therapeutic, drug delivery, and medical device programs from early development through GMP manufacturing.

Laysan Bio firmographics

Firmographics
Name
Laysan Bio
Legal name
Laysan Bio, Inc.
Website
https://laysanbio.com
Company type
Private
Founded year
2006
Operating status
Acquired
Headcount range
11–50 employees
Short description
Laysan Bio is a privately-held life sciences company that manufactures activated polyethylene glycol (PEG) reagents and bioconjugation chemistries used by pharmaceutical, drug delivery, and medical device developers, now operating as a subsidiary of CDMO Gannet BioChem.
Ownership category
akta.pro rank

Laysan Bio industry classification

Industry
Product category
PEG Reagents
NAICS
Pharmaceutical and Medicine Manufacturing (32541)
SIC
Plastic Materials, Synth Resins & Nonvulcan Elastomers (2821)
akta.pro industry
PRIMARYHLAGAHAI
Solid-State Chemistry & Preformulation (Polymorph/Crystallization)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYIMANABAK
Medical & Food-Contact Specialty Compounds

Keywords

  • PEG reagents
  • Bioconjugation services
  • Activated polymers
  • Pharmaceutical manufacturing
  • Drug delivery chemicals

Where Laysan Bio is headquartered

Location

Headquarters

HQ city
Arab
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Laysan Bio business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

  1. PEG Reagent Product Sales: Sale of activated polyethylene glycol reagents and related chemical products to pharmaceutical, biotechnology, and medical device companies. Products sold include cGMP-manufactured and catalog products across multiple functional categories (Esters, Maleimides, Amines, etc.). Pricing ranges from $24 to $1,200 depending on product type and quantity.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goIndividual PEG reagent products with quantity-based pricing

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Laysan Bio product offering

Product offering

Core offering

Laysan Bio manufactures and supplies activated polyethylene glycol (PEG) reagents for pharmaceutical, biotechnology, and medical device applications. The product portfolio spans cGMP-manufactured PEGs and catalog-grade reagents across monofunctional, bifunctional, heterobifunctional, and multi-arm configurations, with over 20 functional group categories including esters, maleimides, amines, thiols, aldehydes, biotins, carboxylic acids, epoxides, and phospholipids. The company also offers bioconjugation expertise to support drug formulation, protein modification, drug delivery systems, and medical device functionalization.

Product overview

Laysan Bio is a life sciences company that supplies activated polyethylene glycol (PEG) reagents for use in therapeutics, devices, and diagnostics. Founded in 1992, the company has supplied PEG reagents for multiple FDA and EU-approved drug and device products. The product portfolio is organized into several categories: cGMP Products for commercial manufacturing; Monofunctional, Bifunctional, Heterobifunctional, and Multi-Arm PEG reagents; and Kits for specific conjugation applications. Products are further categorized by functional group including Esters (NHS, SAS, SC, SG, SS, SVA), Maleimides (MAL), Amines (NH2), Thiols (SH), Aldehydes, Acrylates, Epoxides, Hydrazides, Hydroxyls, Nitrophenyl Carbonates, Orthopyridyl Disulfides, Phospholipids, Protected Amines, Silanes, Biotins, Carboxylic Acids, and Valeric Acids. Featured products include MAL-PEG-SVA (heterobifunctional), mPEG2-NHS (monofunctional), mPEG-SH-4MW KIT (thiol kit), and mPEG2-MAL (monofunctional). The company operates a robust quality system supporting cGMP-manufactured products. In January 2026, Laysan Bio was acquired by Gannet BioChem, a specialty Contract Development and Manufacturing Organization backed by Ampersand Capital Partners.

Differentiator

Problem solved

Functional benefit

Products and services

  • cGMP PEG Products
  • Monofunctional PEG Reagents
  • Bifunctional PEG Reagents
  • Heterobifunctional PEG Reagents
  • Multi-Arm (4 Arm) PEG Reagents
  • PEG Reagent Kits
  • MAL-PEG-SVA Heterobifunctional PEG reagent with maleimide (MAL) and succinimidyl valerate (SVA) functional groups for site-specific protein and peptide conjugation. Price range: $195.00 to $1,200.00.
  • mPEG2-NHS Monofunctional PEG reagent with N-hydroxysuccinimide (NHS) ester for amine-reactive bioconjugation to proteins and peptides. Price range: $275.00 to $825.00.
  • mPEG-SH-4MW KIT mPEG-thiol kit with 4 molecular weight options for thiol-reactive conjugation and crosslinking applications. Price: $120.00.
  • mPEG2-MAL Monofunctional PEG reagent with maleimide functional group for selective thiol-reactive bioconjugation. Price range: $270.00 to $810.00.
  • NH2-PEG-NH2 Bifunctional amine PEG reagent for crosslinking applications with primary amine reactivity. Price range: $24.00 to $270.00.
  • ACRL-PEG-ACRL Bifunctional acrylate PEG reagent for polymerizable conjugation and surface modification applications. Price range: $50.00 to $300.00.
  • SAS-PEG-SAS Bifunctional PEG reagent with succinimidyl succinate (SAS) ester groups for amine-reactive applications. Price range: $65.00 to $345.00.

Companies that use Laysan Bio

Customer profile

Segments3 records

Ideal customer profiles3 records

Laysan Bio technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Laysan Bio partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Gannet BioChemflagshipOthers · 22 January 2026Gannet BioChem, a specialty Contract Development and Manufacturing Organization (CDMO), acquired Laysan Bio to expand its activated polymer and bioconjugation capabilities. The acquisition combines Laysan Bio's technical expertise, quality systems, and customer relationships with Gannet BioChem's CDMO platform serving advanced therapeutic, drug delivery, and medical device programs. Post-acquisition, Laysan Bio operates as part of Gannet BioChem's integrated platform.

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

Laysan Bio competitors and assessment

Company assessment

Direct peers

  • NOF Corporation: NOF Corporation is a leading manufacturer of specialty chemicals with an established PEG reagent and bioconjugation business (including SUNBRIGHT® activated PEGs) serving pharmaceutical and medical device customers globally — directly overlapping with Laysan Bio's core activated PEG reagent offering.
  • Polysciences, Inc. Polysciences manufactures specialty polymers, monomers, and PEG derivatives for life sciences and biomedical applications, with directly overlapping specialty polymer chemistry capabilities and shared pharmaceutical/biotech customers.
  • Creative PEGWorks: Creative PEGWorks specializes in activated PEG derivatives and PEGylation reagents for drug delivery and bioconjugation, with a catalog and customer base that directly overlap with Laysan Bio's PEG reagent product line.
  • BroadPharm: BroadPharm is a manufacturer of activated PEG reagents and PEG derivatives serving pharma, biotech, and academic customers with a catalog comparable in scope to Laysan Bio's, including bioconjugation and drug delivery applications.
  • Quanta BioDesign: Quanta BioDesign develops and supplies PEG derivatives and dPEG®-based linkers for bioconjugation and drug delivery research and manufacturing, directly comparable to Laysan Bio's specialty PEG reagent and bioconjugation offerings.
  • Jenkem Technology USA: Jenkem Technology manufactures and globally distributes activated PEG reagents with broad functional-group coverage, directly competing with Laysan Bio in monofunctional, bifunctional, heterobifunctional, and multi-arm PEG reagents for bioconjugation applications.

Broad incumbents

  • TCI America: TCI America supplies specialty chemicals, including PEG derivatives and activated reagents, to pharma, biotech, and academic customers — competing in adjacent SKUs with Laysan Bio's PEG reagent catalog across broader specialty chemistry.
  • Thermo Fisher Scientific: Thermo Fisher Scientific supplies PEG reagents, bioconjugation products, and specialty chemicals within a much broader life sciences tools and reagents portfolio, providing commercial-stage alternatives for many of Laysan Bio's pharmaceutical and biotech customers.
  • MilliporeSigma (Sigma-Aldrich): MilliporeSigma, the life science business of Merck KGaA, is a broad incumbent supplying catalog PEG reagents, specialty chemicals, and bioconjugation consumables alongside a much larger life sciences portfolio — competing with Laysan Bio across many of the same functional PEG reagent SKUs.

Others

  • Gannet BioChem: Gannet BioChem is now Laysan Bio's parent company and a specialty CDMO supporting advanced therapeutics and drug delivery programs. As the acquirer/platform, it is operationally integrated with Laysan Bio and offers the broader CDMO context in which Laysan Bio's PEG reagents are commercialized.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Laysan Bio social profiles

Digital presence

Laysan Bio financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Laysan Bio leadership team

Management profile

Number of profiles

Profiles1 record

Laysan Bio funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Laysan Bio M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laysan Bio

What does Laysan Bio do?

Laysan Bio manufactures and supplies activated polyethylene glycol (PEG) reagents for pharmaceutical, biotechnology, and medical device applications. The product portfolio spans cGMP-manufactured PEGs and catalog-grade reagents across monofunctional, bifunctional, heterobifunctional, and multi-arm configurations, with over 20 functional group categories including esters, maleimides, amines, thiols, aldehydes, biotins, carboxylic acids, epoxides, and phospholipids. The company also offers bioconjugation expertise to support drug formulation, protein modification, drug delivery systems, and medical device functionalization.

Is Laysan Bio a public or private company?

Laysan Bio is a private company. It is classified as corporate owned and is currently acquired.

When was Laysan Bio founded?

Laysan Bio was founded in 2006. It employs 11 to 50 people.

Where is Laysan Bio based?

Laysan Bio is headquartered in Arab, United States, in the North America region.

How does Laysan Bio make money?

One revenue line is on record: PEG Reagent Product Sales.

Who are Laysan Bio's main competitors?

Direct peers on record are NOF Corporation, Polysciences, Inc., Creative PEGWorks, BroadPharm, Quanta BioDesign and Jenkem Technology USA. Broad incumbents are TCI America, Thermo Fisher Scientific and MilliporeSigma (Sigma-Aldrich). Gannet BioChem is listed as an others.

Does Laysan Bio have an API?

No public API is recorded for Laysan Bio.

What industry is Laysan Bio in?

Laysan Bio's product category is PEG Reagents. Its primary akta.pro industry code is HLAGAHAI, Solid-State Chemistry & Preformulation (Polymorph/Crystallization), with a secondary code of IMANABAK, Medical & Food-Contact Specialty Compounds. Its NAICS code is 32541 and its SIC code is 2821.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PharmasourceGannet BioChem Acquires Laysan Bio to Expand Activated Polymer CapabilitiesGannet BioChem has acquired Laysan Bio, a life sciences company based in Arab, Alabama, to expand its activated polymer and bioconjugation capabilities. The acquisition strengthens Gannet BioChem's ability to support partners from early development through GMP manufacturing across advanced therapeutics, drug delivery, and medical device programmes. This transaction aligns with Gannet BioChem's strategy to invest in specialised technologies and talent within its CDMO and contract manufacturing operations.GlobeNewswireGannet BioChem Acquires Laysan Bio to Expand Activated Polymer and Bioconjugation CapabilitiesGannet BioChem acquired Laysan Bio, a life sciences company in Arab, Alabama, to expand its activated polymer and bioconjugation capabilities. The deal strengthens Gannet's platform for advanced therapeutic, drug delivery, and medical device programs, with Laysan Bio's experience complementing Gannet's manufacturing. The acquisition supports Gannet's strategy to invest in specialized technologies and talent.GlobeNewswireGannet BioChem Acquires Laysan Bio to Expand Activated Polymer and Bioconjugation CapabilitiesGannet BioChem, a specialty Contract Development and Manufacturing Organization backed by Ampersand Capital Partners, has acquired Laysan Bio, a life sciences company based in Arab, Alabama. The acquisition enhances Gannet BioChem's capabilities in activated polymer technologies, PEG reagents, and bioconjugation services while expanding its ability to support partners from early development through GMP manufacturing. Laysan Bio, founded nearly two decades ago, has supplied PEG reagents for multiple FDA and EU-approved drug and device products, and the deal aligns with Gannet BioChem's strategy to invest in specialized technologies and talent in this sector.AmpersandcapitalGannet BioChem Acquires Laysan Bio to Expand Activated Polymer and Bioconjugation CapabilitiesGannet BioChem, a specialty Contract Development and Manufacturing Organization backed by Ampersand Capital Partners, announced the acquisition of Laysan Bio, a life sciences company based in Arab, Alabama. The deal strengthens Gannet BioChem's capabilities in activated polymer technologies, including PEG reagents and bioconjugation, enhancing its ability to support pharmaceutical partners from early development through GMP manufacturing. Laysan Bio, founded nearly two decades ago, has played a role in supplying PEG reagents for multiple FDA and EU-approved drug and device products.ContractpharmaGannet BioChem Acquires Laysan BioGannet BioChem, a specialty Contract Development and Manufacturing Organization backed by private equity firm Ampersand Capital Partners, has acquired Laysan Bio, a life sciences company based in Arab, Alabama. The acquisition strengthens Gannet BioChem's capabilities in activated polymer technologies, including PEG reagents and bioconjugation, while enhancing its ability to support partners from early development through GMP manufacturing. Laysan Bio, founded nearly two decades ago, will contribute its technical expertise, quality systems, and customer relationships to Gannet BioChem's platform serving advanced therapeutic, drug delivery, and medical device programs.